Compare NBP & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBP | CDZI |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.5M | 267.4M |
| IPO Year | 2019 | 1996 |
| Metric | NBP | CDZI |
|---|---|---|
| Price | $1.97 | $3.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 233.2K | ★ 932.6K |
| Earning Date | 04-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,313,000.00 |
| Revenue This Year | N/A | $12.97 |
| Revenue Next Year | N/A | $102.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 69.79 |
| 52 Week Low | $1.46 | $2.87 |
| 52 Week High | $5.19 | $6.96 |
| Indicator | NBP | CDZI |
|---|---|---|
| Relative Strength Index (RSI) | 64.83 | 50.47 |
| Support Level | $1.67 | $2.87 |
| Resistance Level | $2.27 | $5.08 |
| Average True Range (ATR) | 0.08 | 0.23 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 96.15 | 76.73 |
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.